Alcoholic Fatty Liver

This book discusses topics highly correlated with тon-alcoholic fatty liver disease (NAFLD) such as the regulation of iron metabolism, the role of the enzyme heparanase in liver steatosis, transcriptional regulation by ERR and its role in pathogenesis, hepatic lipid homeostasis, therapeutic approaches to NAFLD, and pathogenesis and significance of HDL as a molecular modifier in NAFLD.

This book presents a systematic and comprehensive revision about nonalcoholic fatty liver disease (NAFLD), highlighting its epidemiological and molecular aspects, as well as its prevention and treatment.

The aim of this Special Issue focusing on "Nutritional Intake and the Risk of Non-Alcoholic Fatty Liver Disease" is to provide an in-depth overview of the role of the intake of different macro- and micronutrients in the development and progression of non-alcoholic fatty liver disease, as well as in its prevention and treatment.

This book provides information on non-alcoholic fatty liver disease (NAFLD) prevalence, etiology, pathogenesis, pathology, diagnosis, and treatment. Chapters cover such topics as experimental work related to the disease, other diseases related to NAFLD, and noninvasive tools for diagnosis.

The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) – which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia – and to share the latest information on evolving approaches to diagnosis and treatment.

The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD).